Director/PDMR Shareholding

RNS Number : 3528I
Creo Medical Group PLC
23 November 2018
 

 

 

Creo Medical Group plc (the "Company")

 

Director/PDMR Dealing

 

The Company announces that it has received notice of exercise of options ("Options") under the Company's EMI Share Option Scheme from Steven Morris, Chief Operating Officer, a PDMR, to subscribe for 336,000 Ordinary Shares of £0.001 each in the Company (the "New Ordinary Shares").  The exercise price of the Options is 15.56 pence each.

 

Following the exercise of these Options Mr Morris will hold 451,325 Ordinary Shares in the Company representing approximately 0.375% per cent. of the Company's issued share capital.

 

Application has been made to AIM for the admission of the New Ordinary Shares to trading on AIM ("Admission") and Admission is expected to occur on or around 29 November 2018.

 

Following the issue of the New Ordinary Shares the Company's total issued share capital will consist of 120,322,945 Ordinary Shares. The Company does not hold any Ordinary Shares in Treasury.  Therefore, following the issue of the New Ordinary Shares the total number of voting rights in the Company is 120,322,945.  This figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Steven Morris

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Operating Officer

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Creo Medical Group plc

b)

 

LEI

 

 

213800H188ZDCWWXFA21

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 0.1 pence each

 

 

Identification code

GB00BZ1BLL44

 

 

b)

 

Nature of the transaction

 

 

Exercise of share options

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

Price(s)

Volume(s)

 

 

 

£0.1556

336,000

 

 

 

 

 

 

d)

 

Aggregated information

 

 

 

- Aggregated volume

N/A - single transaction

 

 

- Price

 

 

 

e)

 

Date of the transaction

 

 

22 November 2018

f)

 

Place of the transaction

 

 

London Stock Exchange

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHLLFSILFLVFIT
UK 100

Latest directors dealings